Research Papers

Scottish MND Register bibliography 1989-2010

1 Chancellor  A,  Swingler  RJ, Fraser H &  Warlow  CP  for  the Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: A prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.  Journal of Neurology, Neurosurgery & Psychiatry 1992; 55:536-541.

2 Swingler RJ, Fraser H, Warlow CP. Motor neurone disease and polio in Scotland.  Journal of Neurology, Neurosurgery   and Psychiatry 1992; 55:1116-1120.

3 Chancellor AM, Warlow CP, Adult onset MND: worldwide mortality, incidence and distribution since 1950 JNNP 1992; 55:1106-15.

4  Chancellor A, Slattery J, Holloway S, Swingler RJ, Fraser  H & Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.  Journal of Neurology. 1993; 240:339-346.

5Chancellor AM, Swingler RJ, Fraser H, Clarke JA, Warlow CP.The the  utility  of  Scottish  morbidity  and  mortality  data   for epidemiological  studies  of  motor neuron  disease.  Journal of Epidemiology and Community Health. 1993; 47:116-120.

6 Chancellor AM, Slattery JM, Fraser H, Warlow CP, Risk factors for MND: a case control study based on patients from the SMNDR JNNP 1993;56:1200-6

7 Willison HJ, Chancellor AM, Paterson G, Veitch J, Singh S, Whitelaw J, Kennedy PG,Warlow CP.
 Antiglycolipid antibodies, immunoglobulins and paraproteins in mnd: a population based case-control study J. Neurol. Sci 1993; 114:209-15.

8 Chancellor AM, Fraser H, Swingler RJ, Holloway SM, Warlow CP for   the   Scottish Motor Neuron Research   Group.   Clinical heterogeneity of familial motor neuron disease:  report of 11 pedigrees from a population-based study in Scotland. Journal of Neurological Sciences 1994; 123:75-76.

9  Jones  C, Swingler RJ, Brock D. Identification of  a  novel SOD1  mutation  in  an apparently  sporadic  amyotrophic  lateral sclerosis  patient  and  the detection of ILE 113  THR  in  three others. Human Molecular Genetics.1994; 3:649-650.

10 Chancellor AM, Davenport RJ, Swingler RJ, Warlow CP.  The Scottish Motor Neuron Disease Register. A model for registers of uncommon diseases in Scotland. Health Bulletin. 1994; 52:342-347.

11 Willison HJ, Chancellor AM, Veithc J, Kennedy PG,Warlow CP. Immunoglobulin G subclasses are normal in MND. J Neurol Sci 1994;124:115-6

12 Jones CT, Swingler RJ, Simpson SA, Brock DJH.  Superoxide dismutase mutations in a cohort of Scottish amyotrophic lateral sclerosis patients. Journal of Medical Genetics 1995; 32:290-292.

13  Davenport  R J, Swingler RJ, Chancellor AM &  Warlow  CP  on behalf  of  the  Scottish Motor Neuron  Disease  Research  Group. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.  Journal of  Neurology, Neurosurgery and Psychiatry 1996;60:147-151

14 Hayward C, Swingler RJ, Simpson SA, Brock DJH.  A specific superoxide  dismutase mutation is on the same genetic  background in sporadic and familial cases of amyotrophic lateral  sclerosis. American Journal of Human Genetics 1996; 59:1165-1167.

15  Radunovic  A,  Leigh PN on behalf of  the  European  Familial Amyotrophic  Lateral Sclerosis group.(Anderson PM, Robberecht W, Baas F, de Belleroche J, Hamida B,Brock DJH, Camu W, Chio A, Collinge J, Conradi S, Courtatier P, Christensen P, Dengler R, Gredal O, Hardiman O, Hawkes C, Hugon J, Idrisoglu H, Ince P, Jensen TS, de Jong V, Kuther G, Malafosse A, Meininger V, Mitchell JD, Mora J, Morrison K, Orrell R, Pall HS, Palmer M, Ronnevi L-O, Sales ML, Schiffer D, Shaw P, Sostarko M, Swash M, Swingler RJ , Troost D, Vassipoulos D, Werdelin L, Wiles CM, Williams A, Young C.) Cu/Zn superoxide  dismutase gene  mutations  in  amyotrophic  lateral   sclerosis:correlation between  genotype  and clinical features.  Journal of Neurology Neurosurgery and Psychiatry 1997; 61:565-572.

16 Hayward C, Minns PA, Swingler RJ, Brock DJH.  Homozygosity for Asn 86 Ser mutation in the Cu-Zn superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. Journal Of Medical Genetics 1998; 35:174-176.

17 Hayward C, Colville S, Swingler RJ, Brock DJH. Molecular Genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999;52:1899-1901

18 Forbes R, Colville S, Swingler RJ. Are the El Escorial and revised El Escorial criteria for Amyotrophic lateral sclerosis reproducible? Journal of Amyotrophic Lateral Sclerosis and Motor Neurone Diseases. 2001; 2(3):135-138.

19 Andreas Jonsson P, Backstrand A, Andersen P, Jacobsson J, parton M, shaw C, Swingler RJ, Shaw PJ, Robberecht W, Ludolph AC, Siddique T, Skvortsova VI, marklund SL. CuZn-Superoxide Dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees. Neurobiology of Disease 2002; 10:327-333.

20 Forbes R, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age and Ageing 2004; 33:1-4.

21 Meininger V, Bensimon G, Bradley WG, Brooks BR, Douillet P, Eisen A, Lacomblez Leigh PN Robberecht W for the Xaliproden study group. Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials. ALS and other motor neuron disorders 2004;5:107-117

22 Forbes RB, Colville S, Swingler RJ for the Scottish Motor Neuron Disease Research Group Frequency, timing and outcome of   gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease: A record linkage study from the Scottish Motor Neuron Disease Register. Journal of Neurology 2004; 25197):813-7.

23 Forbes RB, Colville S, Cran GW, Swingler RJ for the Scottish Motor Neuron Disease Research Group. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neuron disease
Journal of Neurology, Neurosurgery and Psychiatry  2004 ; Dec;75(12):1753-1755

24 Beghi e, Chio A, Logroscino, GL, Hardiman, H, Herrero E, Leone M, Millul A, Mitchell D, Salas T, Esteban J, Stevic Z, Swingler RJ, Traynor B, de Visser M. 17th ENMC International Workshop: Implementation of a European Registry of ALS Naarden, The Netherlands, 8-10 October 2004. Neuromuscular Disorders 2006; 16:46-53.

25 Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler RJ, Kieran D, Prehn J, Morrison KE, Green A, Ravi Acharya K, Brown RH, Hardiman O. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nature Genetics 2006:38:411-3

26 Colville S, Swingler RJ, Grant I, Williams F. A population based study of respiratory function in motor neurone disease patients living in Tayside and North East Fife, Scotland. Journal of Neurology. 2007; 254:453-458.

27 Forbes RB, Shuna Colville S, Parratt J, Swingler RJ for the Scottish Motor Neuron Disease Research Group. Incidence of motor neurone disease in Scotland. Journal of Neurology 2007;254:866-869

28  Wendy J. Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, Carsten Russ, Kristen E. Auwarter, Kelly E. Glajch, Nicolas Dupre, Robert J. Swingler, , Shaun Purcell, Caroline Hayward, Peter C. Sapp, Diane McKenna-Yasek, Paul N. Valdmanis, Jean-Pierre Bouchard, Vincent Meininger, Betsy A. Hosler, Jonathan D. Glass, Meraida Polack, Guy A. Rouleau,, Jang-Ho J. Cha, Orla Hardiman,, Robert H. Brown Jr. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis 2008;9:229-37

29 Kurian K, Forbes RB, Colville S,  Swingler RJ. Cause of death and clinical grading criteria in a cohort of ALS cases undergoing autopsy from the Scottish Motor Neurone Disease Register. Journal of Neurology, Neurosurgery and Psychiatry 2009:80:84-87

30 Beghi E, Pupillo E, Zoccolella S; European Amyotrophic Lateral Sclerosis Consortium (EURALS). 148th ENMC international workshop on the scientific contributions of the EURALS consortium on Amyotrophic Lateral Sclerosis. Neuromuscular Disorders 2009;19:379-81

31  Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. The Incidence of Amyotrophic Lateral Sclerosis in Europe Journal of Neurology, Neurosurgery and Psychiatry 2010; 81: 385-90.

32 Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, Swingler R, Traynor BJ. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler. 2010 May 3; 11(3):289-92.


33  Chancellor  A,  Swingler RJ, Carstairs  V,  Elton  R,  Warlow CP. Affluence, age and Motor Neurone Disease.(letter). Journal of Epidemiology and Community Health. 1992; 46:172-173.

34   Jones C, Brock D, Chancellor A, Warlow C & Swingler RJ. SOD1 mutations   in   patients with sporadic   amyotrophic   lateral sclerosis (letter). Lancet 1993; 342:1050-1051.

35  Swingler  RJ, Jones CT, Brock DJH. superoxide dismutase  and amyotrophic lateral sclerosis (letter). Lancet 1995; 345:391.

36 Swingler RJ. Controversial treatments for spinal cord injuries Lancet 2005; 365:841-2.

37 Logroscino G, Beghi E, Hardiman O, Chio A, Mitchell JD, Swingler RJ, Traynor B for EURALS. Effect of referral bias on assessing survival in ALS Neurology 2007; 69:939.

Reviews, Annotations, Comments and Editorials.

38 Chancellor AM, Mitchell JD, Swingler RJ. The first description of idiopathic progressive bulbar palsy. Journal of Neurology, Neurosurgery and Psychiatry.1993; 56:270.

39 Chancellor AM, Diagnosing MND BMJ 1996;312:650-1

40 Swingler RJ for UK Motor Neurone Disease Interest Group. Guidelines for the management of motor neurone disease. Association of British Neurologists, London, 2000.

41 Pritchard J & Swingler RJ. Motor Neurone Disease (review), Scottish Medical Journal 2000; 45:4-7.

42  Beghi E, Logroscino G,Chiò A, Hardiman O,  Mitchell D, Swingler R, Traynor B; on behalf of the EURALS Consortium. The epidemiology of ALS and the role of population-based registries. Biochem Biophys Acta  2006; 1762:1150-57;

43 Beghi E, Mennini T, Bendotti, C, Bigini P, Logoroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, Traynor B, Al-Chalabi A. The heterogeneity of amyotrophic lateral sclerosis: a possible explanation for treatment failure. Current Medicinal Chemistry 2007; 14:3185-3200.

44  Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, Swingler RJ, Beghi E for the EURALS consortium. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. Journal of Neurology, Neurosurgery and Psychiatry 2008; 79:6-11.

45 Chio A, Traynor BJ, Swingler RJ, Mitchell D, Hardiman O, Mora G, Beghi E, Logroscino G, on behalf of the EURALS consortium.   Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthens the previous findings. Journal of Neurological Science. 2008; 14:292-299.

46  Chio, A. Logroscino, G, Hardiman O, Swingler RJ, Mitchell J, Beghi E, Traynor B.  Prognostic factors in ALS: a critical review. Amyotrophic Lateral Sclerosis 2008:1-14

47 The Prognosis of amyotrophic lateral sclerosis. (Editorial Comment). Swingler RJ. Journal of Neurology, Neurosurgery and Psychiatry 2010 epub.


RJ Swingler 10/07/10